11 results
Pain Assessment and Management Initiative (PAMI) - Opioid Prescribing and Equianalgesic Chart - Agents and Dosing

#Management
Equianalgesic Chart - Agents ... and Dosing #Management ... #Pain #Pharmacology ... Equianalgesics #Conversion ... #Doses #Dosing
ACEI Antihypertensive Dose Comparison. Consider divided (BID) regimen for better pre-dose (trough) BP control for the
Antihypertensive Dose ... Comparison. ... for better pre-dose ... ACEInhibitor #ACEIs #Dosing ... #Conversion #Pharmacology
Insulin Dosing Basics - Initiating Insulin for T2DM and Converting Insulin Products 

Insulin dosing can be
titrating insulin doses ... , decrease the dose ... , decrease the dose ... #Conversion #Initiating ... #Prescribing #Pharmacology
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
Potassium-Binding Agents ... 10 g QD (adjust dose ... Usual maintenance dose ... g QD; increase dose ... #table #comparison
ANGIOTENSIN II RECEPTOR ANTAGONIST (ARB) DOSING:
TOOL FOR SWITCHING BETWEEN AGENTS IN CANADA
The information provided is intended
ANTAGONIST (ARB) DOSING ... an alternative agent ... Doses should be ... ReceptorBlocker #Pharmacology ... #Conversion #Switching
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
a maintenance dose ... after the last dose ... or ticagrelor dose ... after the last dose ... after the last dose
Eczematous Skin Rash - Differential Diagnosis Algorithm
Eczematous - Pruritic/Scaly/Erythematous lesions. Usually poorly demarcated
 • Atopic Dermatitis
Eczematous Skin Rash - Differential ... Diagnosis Algorithm ... requires high doses ... of the agent. ... #causes
Acute Atrial Fibrillation - Initial Options for Rate Control
Diltiazem IV
 •  Rapid onset and rapidly
ADHF • Risks conversion ... IV bolus can cause ... • 3rd line agent ... • Does not cause ... Rate #Control #pharmacology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
these injectable agents ... over injectable agents ... p-Aminosalicylic acid, High-dose ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity
Anthracyclines cause cardiomyopathy:
 ✖ Reduction in left ventricular ejection fraction
with increasing doses ... at cumulative doses ... HER2 agents cause ... Track cumulative dose ... Anthracycline: Reduce dose